Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease

被引:222
|
作者
Vivante, Asaf [1 ,2 ]
Golan, Eliezer [2 ,3 ]
Tzur, Dorit
Leiba, Adi [2 ]
Tirosh, Amir [7 ]
Skorecki, Karl [4 ,5 ]
Calderon-Margalit, Ronit [6 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Israeli Def Forces Med Corps, Chaim Sheba Med Ctr, Dept Pediat,Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Israel Renal Registry, Bristol, Avon, England
[4] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, Haifa, Israel
[5] Technion Israel Inst Technol, Res Inst, Haifa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
关键词
OBESITY-RELATED GLOMERULOPATHY; US CHILDREN; KIDNEY-DISEASE; UNITED-STATES; FOLLOW-UP; PREVALENCE; OVERWEIGHT; POPULATION; PROTEINURIA; ASSOCIATION;
D O I
10.1001/2013.jamainternmed.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (>= 95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
引用
收藏
页码:1644 / 1650
页数:7
相关论文
共 50 条
  • [41] Quality of life of adolescents with end-stage renal disease and kidney transplant
    Riano-Galan, Isolina
    Malaga, Serafin
    Rajmil, Luis
    Ariceta, Gema
    Navarro, Mercedes
    Loris, Cesar
    Vallo, Alfredo
    PEDIATRIC NEPHROLOGY, 2009, 24 (08) : 1561 - 1568
  • [42] Increased risk of end-stage renal disease in individuals with coeliac disease
    Welander, Adina
    Prutz, Karl-Goran
    Fored, Michael
    Ludvigsson, Jonas F.
    GUT, 2012, 61 (01) : 64 - 68
  • [43] Obesity, metabolic health, and the risk of end-stage renal disease
    Panwar, Bhupesh
    Hanks, Lynae J.
    Tanner, Rikki M.
    Muntner, Paul
    Kramer, Holly
    McClellan, William M.
    Warnock, David G.
    Judd, Suzanne E.
    Gutierrez, Orlando M.
    KIDNEY INTERNATIONAL, 2015, 87 (06) : 1216 - 1222
  • [44] Apolipoprotein B is a risk factor for end-stage renal disease
    Kwon, Soie
    Kim, Dong Ki
    Oh, Kook-Hwan
    Joo, Kwon Wook
    Lim, Chun Soo
    Kim, Yon Su
    Han, Seung Seok
    CLINICAL KIDNEY JOURNAL, 2021, 14 (02) : 617 - 623
  • [45] Cardiovascular risk in diabetic end-stage renal disease patients
    Wang, Angela Yee-Moon
    JOURNAL OF DIABETES, 2011, 3 (02) : 119 - 131
  • [46] Cardiovascular risk in end-stage renal disease: vascular aspects
    London, GM
    Marchais, SJ
    Metivier, F
    Guerin, AP
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 97 - 104
  • [47] Diabetes increases risk of end-stage renal disease in SLE
    McHugh, Jessica
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (04) : 193 - 193
  • [48] The challenge of cardiovascular risk factors in end-stage renal disease
    Covic, A
    Gusbeth-Tatomir, P
    Goldsmith, DJA
    JOURNAL OF NEPHROLOGY, 2003, 16 (04) : 476 - 486
  • [49] Cumulative hypertension burden and risk of end-stage renal disease
    Chang Seong Kim
    Bongseong Kim
    Hong Sang Choi
    Eun Hui Bae
    Seong Kwon Ma
    Kyung-Do Han
    Soo Wan Kim
    Hypertension Research, 2021, 44 : 1652 - 1661
  • [50] The risk for end-stage renal disease is increased after burn
    Helantera, Ilkka
    Koljonen, Virve
    Finne, Patrik
    Tukiainen, Erkki
    Gissler, Mika
    BURNS, 2016, 42 (02) : 316 - 321